Last reviewed · How we verify
Double dosing of beta-lactam antibiotic — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Double dosing of beta-lactam antibiotic (Double dosing of beta-lactam antibiotic) — Erasmus Medical Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Double dosing of beta-lactam antibiotic TARGET | Double dosing of beta-lactam antibiotic | Erasmus Medical Center | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Double dosing of beta-lactam antibiotic CI watch — RSS
- Double dosing of beta-lactam antibiotic CI watch — Atom
- Double dosing of beta-lactam antibiotic CI watch — JSON
- Double dosing of beta-lactam antibiotic alone — RSS
Cite this brief
Drug Landscape (2026). Double dosing of beta-lactam antibiotic — Competitive Intelligence Brief. https://druglandscape.com/ci/double-dosing-of-beta-lactam-antibiotic. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab